Assessment of the awareness, perception and practice of personalized medicine service among pharmacists in Osun State, Southwestern Nigeria Évaluation de la sensibilisation, de la perception et de la pratique des services de médecine personnalisée chez les pharmaciens de l'État d'Osun, dans le sud-ouest du Nigéria

Main Article Content

Adebanjo J. Adegbola
Kayode J. Awogbemi
Yinka Ojo
Olugbenga T. Fajemirokun

Abstract

ENGLISH


Background: The era of personalized medicine service (PMS) is emerging globally and it has contributed immensely to effective use of medicine and medical treatment. However, this may not hold for the healthcare system in several climes where the concept has not been embraced by practitioners. Thus, there is a need to assess the perception and extent of practice of PMS.


Objective: This study was carried out to evaluate the perception of pharmacists in Osun State about PMS, and to determine the extent to which it is utilized in their practice.


Methods: A cross-sectional survey of 207 pharmacists was carried out in Osun state using a pre-tested questionnaire to gather information on respondents' knowledge and extent of practice of PMS. Statistical analyses were performed to describe the variables and to evaluate the extent of associations and the significance of such associations among the study variables.


Results: Out of the 207 questionnaire administered, one-hundred and fifty-eight pharmacists responded to this survey within the stipulated period. Out of this number, 104 (representing 65.8%) were males. Some (45.6%) practiced in hospital. Fifty-two percent had not offered PMS before, and a perception rating of 2.86 ± 0.72 on a 4-point Likert scale was recorded among the respondents. The study reported a strong significant association in the perception of PMS and the area of practice (p = 0.018) as well as job status (p=0.009). Similarly, among those who had previously offered PMS, areas of practice and qualification of the respondents were significantly associated with the extent of practice of PMS.


Conclusion: A fair perception of PMS was reported among the pharmacists in Osun state but the extent of practice was
abysmally low.


FRENCH


Contexte: L'émergence des services de médecine personnalisés (SMP) à l'échelle mondiale et a contribué de manière considérable à l'utilisation efficace des médicaments et des traitements médicaux. Cependant, cela pourrait ne pas être le cas pour le système de santé dans plusieurs pays où le concept n'a pas été adopté par les praticiens. Il est donc nécessaire d'évaluer la perception et l'étendue de la pratique des SMP.


Objectif: Cette étude a été menée pour évaluer la perception des pharmaciens de l'État d'Osun à propos du SMP et pour déterminer dans quelle mesure il est utilisé dans leur pratique.


Méthodes: Une enquête transversale a été menée auprès de 207 pharmaciens dans l'État d'Osun à l'aide d'un questionnaire pré-testé pour recueillir des informations sur la connaissance, la perception et l'étendue de la pratique des SMP par les répondants. Des analyses statistiques ont été effectuées pour décrire les variables et évaluer l'étendue des associations et la signification de ces associations parmi les variables de l'étude.


Résultats: Sur les 207 questionnaires administrés, cent cinquante-huit pharmaciens ont répondu à cette enquête dans le délai imparti. De ce nombre, 104 (soit 65,8 %) étaient des hommes. Certains (45,6 %) exerçaient en milieu hospitalier. Cinquante-deux pour cent d'entre eux n'avaient jamais proposé de SMP auparavant et une note de perception de 2,86 ± 0,72 sur une échelle de Likert à 4 points a été enregistrée parmi les répondants. L'étude a révélé une forte association significative entre la perception du SMP et le domaine de pratique (p = 0,018) ainsi que le statut professionnel (p = 0,009). De même, parmi ceux qui avaient déjà proposé du SMP, les domaines de pratique et la qualification des répondants étaient significativement associés à l'étendue de la pratique du SMP.


Conclusion: Les pharmaciens de l'État d'Osun ont une perception équitable du SMP, mais le dégrée de la pratique est extrêmement faible. 

Downloads

Download data is not yet available.

Article Details

How to Cite
Adegbola, A. J., Awogbemi, K. J., Ojo, Y., & Fajemirokun, O. T. (2025). Assessment of the awareness, perception and practice of personalized medicine service among pharmacists in Osun State, Southwestern Nigeria: Évaluation de la sensibilisation, de la perception et de la pratique des services de médecine personnalisée chez les pharmaciens de l’État d’Osun, dans le sud-ouest du Nigéria. West African Journal of Pharmacy, 36(1), 1-13. https://doi.org/10.60787/wajp.vol36no1.371
Section
Articles

References

1. Mason-Suares H, Sweetser DA, Lindeman NI, Morton CC (2016). Training the Future Leaders in ersonalized Medicine. Journal of Personalized Medicine, 6(1).

2. Brazeau DA, Brazeau GA (2011). Principles of the human genome and Pharmacogenomics. Washington, DC: American Pharmacists Association; 1-8.

3. Marouani H, Woloch C, Benay S, Frances N, Iliadis A (2012). Progress in strategies for dosage regimen individualization. Curr Top Med Chem.; 12(15):1669-77

4. Conti R, Veenstra DL, Armstrong K, Lesko LJ, GrosseSD (2014). Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities. Med. Decis. Making. 30(3); 328- 340

5. FIP(2015). International Federation of Pharmaceutical. Making Medication Unique through personalized dosing. 2015 Conference.

Netherland.

6. Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PF (2014). Implementation of personalized medicine services in community pharmacies: Perceptions of independent community pharmacists. Journal America Pharm. Assoc. 54:510-517. doi: 10.1331/JAPhA.2014.13041

7. Owolabi P, Adam Y, Adebiyi E. (2023) Personalizing medicine in Africa: current state, progress and challenges. Front Genet.14:1233338.

8. Weiss ST, Shin MS (2016). Infrastructure for Personalized Medicine at Partners HealthCare. Journal of Personalized Medicine, 6(13).

9. Mokhtar IA (2010). Formal and informal learning opportunities in government organisations: Experiences of public sector employees from six Asian nations. Australian Journal of Adult Learning; 50(2); 387-410.

10. Faulkner, E., Annemans, L., Garrison, L., Helfand, M., Holtorf, A., Hornberger, J., Hughes, D. et al. (2012). "Challenges in theDevelopment and Reimbursement of Personalized Medicine-Payer and Manufacturer Perspectives and Implications for Health Economics and OutcomesResearch: A Report of the ISPOR Personalized Medicine Special Interest Group." Value in Health (Elsevier Science) 15 (8): 1162-71.

11. Yau, A., Aniza, B.A.A.,& Mainul, H. (2015). Knowledge, Attitude and Practice Concerning Pharmacogenomics among Pharmacists: A Systematic Review. Journal of Young Pharmacists, 7(3):145-154.

12. Naimat F, Fahrni ML, Purushothaman S, Abdul Ghani MN, Chumnumwat S and Babar Z-U-D (2022) Community pharmacists' perceived value on precision medicine, desired training components, and exposure during pharmacy education: Malaysia's experience. Front. Pharmacol. 13:978141. doi: 10.3389/fphar.2022.978141

13. Jairoun AA, Al-Hemyari SS, Shahwan M, Al-Ani M, Yaseen MA, Al-Aawad MH, Alnuaimi GR, Mahalakshmi B (2024). Empowering precision

medicine: Insights from a National Survey on Pharmacogenomics Knowledge, Attitudes, and Perceptions among Community Pharmacists in the UAE. Exploratory Research in Clinical and Social Pharmacy 16: 100508

14. Moghadam MJF, Peiravian F, Naderi A, Rajabzadeh A, Rasekha HR (2014). An Analysis of Job Satisfaction among Iranian Pharmacists through Various Job Characteristics. Iran Journal Pharmacy Research. 13(3): 1087-1096.

15. Abramowitz PW (2009). Harvey A. K. Whitney Lecture: The evolution and metamorphosis of the Pharmacy practice model. America Journal Health- Syst. Pharm. 66:1437- 46.

16. Olajide AT, Asuzu MC, Obembe TA (2015). Doctor- Nurse Conflict in Nigerian Hospitals: Causes and Modes of Expression. British Journal of Medicine & Medical Research. 9(10): 1-12.

17. Bannur Z, Bahaman S, Salleh MZ, Ten LK (2014). Pharmacogenomics based practice in Malaysia: The Attitude, knowledge and adoption by the healthcare professionals. The International Medical Journal Malaysia. 13(1): 44-50.

18. Durosinmi MA, Faluyi JO, Oyekunle AA, Salawu L, Adedinran IA, Akinola NO, Bamgbade OO, Okanny CC, Akanmu S, Ogba OP et al., (2008). The use of imatinib mesylate in Nigerians with chronic myeloid leukemia. Cellular Therapy and Transplantation 1(2): 58-62.

19. Adeniji AA, Dulal S, Martin MG (2021). Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve Status Quo. World Journal of Oncology 12(2-3):50-60.

20. Tolani MA, Zubairu IH, Balarabe K, Awaisu M, Abdullahi M, Adeniji AA, Shehu Salihu SS, Bello A, Tagawa ST. (2024) Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: Perspective from a low- and middle- income country in sub-Saharan Africa. Urologic Oncology: Seminars and Original Investigations 42(12): 411-420

Similar Articles

You may also start an advanced similarity search for this article.